The Breast Imaging market size in North America is forecasted to grow USD 2.02 billion by the end of 2026 from USD 1.35 billion in 2021, registering a CAGR of 8.5% during the forecast period.
The prominent factors driving the growth of the North America Breast Imaging market are increasing commercialization of the healthcare system because of the rise in the number of people undergoing advanced treatments, expansion of network distribution owing to a supportive government, and efficient regulatory procedures. Enhancements in breast imaging modalities, the higher occurrence rate of breast cancer alongside government backing for cancer prevention, escalation of research & developments in breast cancer therapies, The relatively less stringent product approval process leading to Launch of new and innovative products by healthcare companies which are offering comfort for the women undergoing screening,
Emerging economies of the North American countries like the United States, Canada, and remaining countries are expected to provide opportunities for the North America Breast imaging market's growth. Due to increasing healthcare expenditures in Canada resulting in product and service portfolio expansion, which is likely to enlarge the growth of the Breast Imaging market in the region, it will impact the North America breast imaging market's growth during the forecast period.
The emergence of advanced imaging systems like nuclear imaging, bioelectric imaging, ultrasound, MRI, near infra-red optical imaging is predicted to offer growth to the North America Breast imaging market during the forecast period.
Also, the changes in reimbursement policies, increase in private and government investments for the development of innovative and advanced breast imaging technologies due to growing demand for breast cancer screenings, drawbacks of existing imaging systems and psychological effects that are associated with overdiagnosis, are expected to provide lucrative opportunities for the growth of the North America breast imaging market during the forecast period.
The high cost of breast imaging systems and budget restrictions, expensive installation and maintenance prices, and patients' psychological health issues due to radiation exposure are the major restraints to the market.
This research report on the North America Breast Imaging Market has been segmented and sub-segmented into the following categories:
Regionally, the North American region accounts for the largest share in the global breast imaging market in 2019. North America held the largest market share due to the increased expenditure in the development of futuristic technologies coupled with the rising awareness amongst patients. Also, the North American region witnessed more cancers in recent years. Breast cancer and prostate cancer are more occurring problems seen in North American countries. According to Breast cancer.org; it reported that there are more than 3.1 Million women fallen prey for breast cancer in the united states as of 2019. Comparatively, than any other cancer’s death ratio for Breast cancer, is reported high. In collaboration with the National Cancer Institute, the American cancer society is playing an essential role in creating awareness for breast cancers and early detection projects. Likewise, (USPSTF), the United States Preventive Services Task Force made up doctors and specialists about innovation and speed up in research activities in new detection techniques and treatments for breast cancers. Canada, Mexico, and the United States hold adult populations more, and hence the ratio of adults detected for Breast cancers and death ratios are high.
Some of the key players dominating the Breast Imaging market in North America are Hologic, Inc., GE Healthcare, Siemens Healthcare, Philips Healthcare, Fujifilm Holdings Corporation Gamma Medica, Inc., Toshiba Corporation, Sonocine, Inc., Aurora Imaging Technology, Inc., and Dilon Technologies, Inc.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.2 Ionizing Technologies
18.104.22.168 Digital Mammography
22.214.171.124 3D Mammography
126.96.36.199 Molecular Breast-Specific Gamma Imaging (MBI/BSGI)
188.8.131.52 Positron Emission Tomography and Computed Tomography (PET-CT)
184.108.40.206 Cone-Beam Computed Tomography (CBCT)
220.127.116.11 Positron Emission Mammography (PEM)
5.1.3 Non-ionizing Technologies
18.104.22.168 Breast MRI
22.214.171.124 Breast Ultrasound
126.96.36.199 Automated Whole-Breast Ultrasound (AWBU)
188.8.131.52 Breast Thermography
184.108.40.206 Optical Imaging
5.1.4 Y-o-Y Growth Analysis, By Type
5.1.5 Market Attractiveness Analysis, By Type
5.1.6 Market Share Analysis, By Type
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
220.127.116.11 By Geographical Area
18.104.22.168 By Type
6.1.4 Market Attractiveness Analysis
22.214.171.124 By Geographical Area
126.96.36.199 By Type
6.1.5 Market Share Analysis
188.8.131.52 By Geographical Area
184.108.40.206 By Type
6.2 United States
7. Strategic Analysis
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Hologic Inc.
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 GE Healthcare
8.3 Siemens Healthcare
8.4 Philips Healthcare
8.5 Fujifilm Holdings Corporation Gamma Medica Inc.
8.6 Toshiba Corporation
8.7 Sonocine Inc.
8.8 Aurora Imaging Technolog Inc.,
8.9 Dilon Technologies, Inc.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures